Werewolf Therapeutics Ownership | Who Owns Werewolf Therapeutics?


OverviewForecastFinancialsChart

Werewolf Therapeutics Ownership Summary


Werewolf Therapeutics is owned by 4.95% institutional investors, 5.62% insiders, and 89.44% retail investors. Ra capital management is the largest institutional shareholder, holding 14.52% of HOWL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.80% of its assets in Werewolf Therapeutics shares.

HOWL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockWerewolf Therapeutics4.95%5.62%89.44%
SectorHealthcare Stocks 35.49%11.75%52.76%
IndustryBiotech Stocks 34.83%11.71%53.46%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management6.68M14.52%$5.56M
Mpm asset management4.31M9.58%$8.49M
Bank of america corp /de/2.15M5.16%$5.24M
Blackrock1.59M3.82%$3.87M
Vanguard group1.41M3.10%$892.70K
Bioimpact capital1.21M2.63%$1.01M
Lynx1 capital management lp657.79K1.43%$547.67K
Sphera funds management626.81K1.36%$521.88K
Dc funds, lp589.10K1.28%$490.49K
Renaissance516.22K1.12%$429.80K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Dc funds, lp589.10K33.01%$490.49K
Mpm asset management4.31M19.08%$8.49M
Lynx1 capital management lp657.79K0.09%$547.67K
Sphera funds management626.81K0.08%$521.88K
Bioimpact capital1.21M0.08%$1.01M
Pfm health sciences, lp401.11K0.06%$790.19K
Ra capital management6.68M0.06%$5.56M
Verdad advisers, lp29.76K0.03%$24.78K
Point72 asia (singapore) pte.13.02K0.00%$25.64K
Ranch capital advisors12.00K0.00%$9.99K

Top Buyers

HolderShares% AssetsChange
Blackrock1.59M0.00%1.42M
Bank of america corp /de/2.15M0.00%266.31K
Vanguard fiduciary trust157.73K-157.73K
Geode capital management389.49K-53.60K
Xtx topco50.93K0.00%50.93K

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp---2.00M
Rubric capital management lp---1.33M
Monashee investment management---890.00K
Eagle health investments lp---700.00K
Verition fund management---233.83K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust157.73K-157.73K$131.39K
Xtx topco50.93K0.00%50.93K$42.40K
Cubist systematic strategies46.71K0.00%46.71K$92.02K
Verdad advisers, lp29.76K0.03%29.76K$24.78K
D. e. shaw17.78K-17.78K$26.31K

Sold Out

HolderChange
Ifp advisors-1.00
True wealth design-13.00
Eversource wealth advisors-35.00
Plante moran financial advisors-50.00
Capital performance advisors llp-60.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202619-62.00%2,276,488-84.55%40.47%10-52.38%3-81.25%
Dec 31, 202531-50.00%3,199,424-84.84%70.32%15-28.57%9-50.00%
Sep 30, 202560-3.23%20,872,525-5.08%461.94%20-33.33%18-
Jun 30, 202565-9.72%22,335,903-18.62%491.32%323.23%19-5.00%
Mar 31, 20251-98.65%1,333,893-95.26%20.07%--100.00%--100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv873.75K1.80%-
Vanguard US Total Market Shares ETF800.28K1.79%-
HBM Healthcare Investments AG Ord396.80K0.91%-60.51K
Vanguard Institutional Extnd Mkt Idx Tr344.23K0.71%-
Fidelity Small Cap Index311.53K0.69%-
BIT Biotech Opportunities S241.06K0.54%-
Vifag 2002 SICAV220.00K0.45%-
Fidelity Extended Market Index218.27K0.45%51.13K
Vanguard Russell 2000 ETF152.99K0.34%1.40K
A4Investments SICAV SIF ACCI IlanaA2EURH150.00K0.31%-

Recent Insider Transactions


DateNameRoleActivityValue
May 13, 2026EVNIN LUKE-Sell$24.13K
May 08, 2026EVNIN LUKE-Sell$214.02K
May 11, 2026EVNIN LUKE-Sell$22.75K
May 12, 2026EVNIN LUKE-Sell$43.45K
May 08, 2026RA CAPITAL MANAGEMENT, L.P.-Sell$249.57K

Insider Transactions Trends


DateBuySell
2026 Q2-19
2026 Q1-11
2025 Q4-100
2025 Q23-
2025 Q1--

HOWL Ownership FAQ


Who Owns Werewolf Therapeutics?

Werewolf Therapeutics shareholders are primarily institutional investors at 4.95%, followed by 5.62% insiders and 89.43% retail investors. The average institutional ownership in Werewolf Therapeutics's industry, Biotech Stocks , is 34.83%, which Werewolf Therapeutics falls below.

Who owns the most shares of Werewolf Therapeutics?

Werewolf Therapeutics’s largest shareholders are Ra capital management (6.68M shares, 14.52%), Mpm asset management (4.31M shares, 9.58%), and Bank of america corp /de/ (2.15M shares, 5.16%). Together, they hold 29.26% of Werewolf Therapeutics’s total shares outstanding.

Does Blackrock own Werewolf Therapeutics?

Yes, BlackRock owns 3.82% of Werewolf Therapeutics, totaling 1.59M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.87M$. In the last quarter, BlackRock increased its holdings by 1.42M shares, a 863.47% change.

Who is Werewolf Therapeutics’s biggest shareholder by percentage of total assets invested?

Dc funds, lp is Werewolf Therapeutics’s biggest shareholder by percentage of total assets invested, with 33.01% of its assets in 589.1K Werewolf Therapeutics shares, valued at 490.49K$.

Who is the top mutual fund holder of Werewolf Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Werewolf Therapeutics shares, with 1.80% of its total shares outstanding invested in 873.74K Werewolf Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools